500% rally in 5 months, 10 lower tracks and a mild rebound: should you ride the dizzying swings of Stallion India?

For investors in Stallion India Fluorochemicals, the past few months have been a dizzying experience. The Mumbai-based company’s shares soared more than 500% between mid-May and mid-October before plunging sharply, losing nearly half their value in a brutal correction that saw ten consecutive lower circuits. After weeks of relentless selling, the stock is finally showing signs of recovery, rising about 5% on Tuesday.The stock’s sharp decline reflected a mix of profit booking, rising valuations and declining liquidity. Many traders who chased the rally near its peak were left trapped as stocks hit back-to-back lower circuits, wiping out much of their gains.

Stallion India’s meteoric rise made it one of the standouts among small cap stocks this year. Unlike the highly volatile small cap counters, there was a method by which investors chased Stallion’s madness. The company operates in a niche sector that experiences consistent long-term growth.According to the annual report, Stallion aims to achieve a CAGR of 30-35% over the next three years while maintaining healthy and sustainable margins. Management has outlined plans to expand into new product categories, join green chemistry trends and enter the semiconductor gases market, a segment that offers high growth and premium margins.

About the company

Founded in 2002 and based in Mumbai, Stallion India Fluorochemicals is engaged in the business of selling refrigerants, industrial gases and allied products. Its activities include debulking, blending and processing of gases for industrial customers, along with the sale of pre-filled cans and small cylinders.

The company has four facilities at Khalapur and Panvel in Maharashtra, Ghiloth in Rajasthan and Manesar in Haryana. Each facility is designed for safe storage and handling of gases in controlled environments that meet industry safety standards.

The company’s gases are used in a wide range of sectors, including air conditioning and refrigeration, fire safety, semiconductors, automotive manufacturing, pharmaceuticals and glass production.

Using its expertise in gases and engineering, Stallion offers customized solutions that help customers optimize processes and improve productivity.

Fundamental vision

Anand Rathi said the company has built a distinct position in the fluorochemicals market through high-quality and cost-effective products and has a market share of around 10% in the Indian fluorochemicals segment.

Globally, the fluorochemicals and specialty gases market is expected to grow at an annual rate of more than 10% between 2024 and 2028, reaching approximately US$16 billion by the end of the period. Growth is driven by urbanization, population growth and rising industrial demand. Among end-user sectors, the automotive industry is expected to remain the largest consumer of fluorochemicals, especially in the case of refrigerant gases.

Hengst’s financial performance has also steadily improved. Between FY22 and FY24, the company’s revenue grew from Rs 186 crore to Rs 236 crore, while net profit rose from Rs 9.7 crore to Rs 14.8 crore. In FY25, the company reported a surge in its numbers, with total revenue rising 61% to Rs 379 crore. EBITDA grew 85% year-on-year to Rs 49.7 crore, and profit after tax more than doubled to Rs 32.3 crore. EBITDA margins improved to 13.1% from 11.4% a year earlier, due to better operational efficiency and product mix.

With its focus on forward integration and plans for backward integration to secure raw materials, the company believes it is well positioned to become a leading player in the Indian fluorochemical ecosystem.

Analysts remain cautiously optimistic about the company’s fundamentals. Bajaj Broking noted that Stallion has carved a niche in a fast-growing market and is poised for sustainable earnings growth, supported by strong demand for refrigerant gases and growing industrial applications.

Technical view

On the technical front, Stallion India’s chart shows tentative signs of recovery after the steep decline. The stock recently recovered from the lower circuit near Rs 223 and rose around 5% today, indicating near-term relief after heavy selling.

According to Riyank Arora, technical analyst at Mehta Equities, the stock remains weak overall as it trades below the major moving averages and the relative strength index is still in the oversold territory. “Immediate support is seen around Rs 190, while resistance is around Rs 260. A sustained trade above Rs 260 could signal the beginning of a short-term recovery, while a break below Rs 190 could lead to renewed weakness.”

(Disclaimer: Recommendations, suggestions, views and opinions expressed by the experts are their own. These do not represent the views of the Economic Times)